XENE Xenon Pharmaceuticals Inc.
Price Chart
Executive Summary
Director Gary Patou filed a Form 144 notice of intent to sell 1,322 shares of Xenon Pharmaceuticals common stock, valued at approximately $70,053 based on the filing date. This is a very small sale relative to the company's $5.1B market cap and appears to be a routine, low-conviction signal.
Actionable Insight
This is a routine, small-dollar insider sale by a director following RSU vesting. No material signal for traders. Monitor for any larger insider sales or changes in ownership patterns ahead of upcoming catalysts.
Key Facts
- Director Gary Patou filed Form 144 to sell 1,322 shares of XENE common stock.
- Estimated sale value is approximately $70,053 based on the filing date.
- The shares were acquired from restricted stock units vesting on 05/31/2026.
- The sale represents a tiny fraction of the company's $5.1B market cap.
- No other insider sales or purchases were reported in the prior 30 days.
Financial Impact
Sale of 1,322 shares worth ~$70,053; negligible relative to $5.1B market cap.
Risk Factors
- Insider sale intent is filed but may not be executed.
- No material risk to stock price from this filing alone.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005710 |
| Document: 0001950047-26-005710-index.html | 0001950047-26-005710 |
| Document: 0001950047-26-005710.txt | 0001950047-26-005710 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
4d ago
|
144
| $51.73 awaiting T+1 | awaiting T+1 | — | $51.21 (−1.01%) |
|
Jun 3, 2026
6d ago
|
8-K
| $52.99 $51.73 | ▼ −2.38% | ▲ +0.22% | $51.21 (−3.36%) |
|
May 7, 2026
4w ago
|
Press Release
| $56.44 $55.78 | ▼ −1.17% | ▼ −1.40% | $51.21 (−9.27%) |
|
Apr 22, 2026
6w ago
|
DEFA14A
| $55.41 $55.24 | ▼ −0.31% | ▼ −1.09% | $51.21 (−7.58%) |
|
Apr 19, 2026
7w ago
|
Press Release
| $57.09 $56.40 | ▼ −1.21% | ▼ −0.56% | $51.21 (−10.30%) |
|
Apr 15, 2026
7w ago
|
Press Release
| $58.88 $58.43 | ▲ +0.76% | ▲ +1.02% | $51.21 (+13.03%) |
|
Apr 13, 2026
8w ago
|
8-K
| $59.35 $58.88 | ▼ −0.79% | ▼ −1.57% | $51.21 (−13.72%) |
|
Apr 7, 2026
9w ago
|
Press Release
| $57.65 $57.54 | ▲ +0.19% | ▲ +2.73% | $51.21 (+11.17%) |
|
Mar 13, 2026
12w ago
|
Insider Cluster
| $55.23 $54.66 | ▲ +1.03% | ▲ +2.06% | $51.21 (+7.28%) |
|
Mar 12, 2026
12w ago
|
Press Release
| $55.23 $54.66 | ▼ −1.03% | ▼ −2.06% | $51.21 (−7.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access